Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000906305-00-000002
Filing Date
2000-02-14
Accepted
2000-02-14 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 CELTRIX PHARMACEUTICALS, INC. SCHEDULE SC 13G 4971
  Complete submission text file 0000906305-00-000002.txt   7059
Mailing Address 2033 GATEWAY PLACE SUITE 600 SAN JOSE CA 95110
Business Address 2033 GATEWAY PLACE SUITE 600 SAN JOSE CA 95110 4089882500
CELTRIX PHARMACEUTICALS INC (Subject) CIK: 0000871395 (see all company filings)

EIN.: 943121462 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-41502 | Film No.: 540641
SIC: 2834 Pharmaceutical Preparations

Mailing Address 354 PEQUOT AVE SOUTHPORT CT 06490
Business Address 354 PEQUOT AVE SOUTHPORT CT 06490 2032540091
DAWSON SAMBERG CAPITAL MANAGEMENT INC /CT (Filed by) CIK: 0000906305 (see all company filings)

EIN.: 061033494 | State of Incorp.: CT | Fiscal Year End: 1231